Fractional, sponsor-embedded executive clinical operations leadership, governance, and execution for local and global oncology, rare disease, and cell and gene therapy (CGT) clinical trial sponsors.
Choice ClinOps provides fractional and embedded executive clinical operations leadership, governance, and execution for high-stakes global oncology, rare disease, and cell and gene therapy (CGT) clinical trials.
Executive-level clinical operations judgment, governance discipline, and execution authority without full-time overhead. Leadership and execution by senior clinical trial operations professionals each with over 20 years of hands-on execution experience. We see the red flags before they turn red and mitigate quickly to keep all aspects of clinical trials green.
Access senior sponsor-side clinical operations leadership without the lag, rigidity, or full-time cost of a permanent hire. Embedded leadership matched to sponsor needs.
Oncology, rare disease, and cell & gene therapy programs require operational judgment that generalist models often miss.
Choice ClinOps does not stop at recommendations. We drive governance, oversight, accountability, alignment, and follow-through - based on over 20 years of countless hands-on clinops experiences solving the same or similar challenges.
Designed for rescue, harmonization, and global execution - without delayed pivots as necessary.
We focus on fund and quality protection, timeline adherence, data integrity, site trust and partnerships, participant and caregiver safety burden awareness and alleviation, and practical operational realism.
Each Choice ClinOps team member holds themselves and is held to the highest quality, ethical, and work standard possible. Each person on the Choice ClinOps team is driven and focused daily on ensuring the top quality, compliant, safe, effective therapeutics reach patients in need through seamless clinical trial operations.
Choice ClinOps partners with global small and mid-size sponsors of oncology, rare disease, and cell and gene therapy (CGT) clinical trials to strengthen continuity, governance, execution, and control during growth, drift, and transition.
You won't know if you don't start the discussion. Schedule an exploratory discussion with Leila Cupersmith. Dive into what your clinical study team is experiencing. Evaluate whether Leila Cupersmith and/or her team have the expertise your team needs.
Post meeting, if agreed, schedule an initial topic-specific diagnostic to be completed by Leila Cupersmith. Each diagnostic is designed to identify the highest-priority operational risks, define near-term action paths, and give leadership a sharper decision framework.